223 related articles for article (PubMed ID: 35295213)
1. The AOP-DB RDF: Applying FAIR Principles to the Semantic Integration of AOP Data Using the Research Description Framework.
Mortensen HM; Martens M; Senn J; Levey T; Evelo CT; Willighagen EL; Exner T
Front Toxicol; 2022; 4():803983. PubMed ID: 35295213
[TBL] [Abstract][Full Text] [Related]
2. Providing Adverse Outcome Pathways from the AOP-Wiki in a Semantic Web Format to Increase Usability and Accessibility of the Content.
Martens M; Evelo CT; Willighagen EL
Appl In Vitro Toxicol; 2022 Mar; 8(1):2-13. PubMed ID: 35388368
[TBL] [Abstract][Full Text] [Related]
3. The 2021 update of the EPA's adverse outcome pathway database.
Mortensen HM; Senn J; Levey T; Langley P; Williams AJ
Sci Data; 2021 Jul; 8(1):169. PubMed ID: 34253739
[TBL] [Abstract][Full Text] [Related]
4. AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.
Pittman ME; Edwards SW; Ives C; Mortensen HM
Toxicol Appl Pharmacol; 2018 Mar; 343():71-83. PubMed ID: 29454060
[TBL] [Abstract][Full Text] [Related]
5. Introducing WikiPathways as a Data-Source to Support Adverse Outcome Pathways for Regulatory Risk Assessment of Chemicals and Nanomaterials.
Martens M; Verbruggen T; Nymark P; Grafström R; Burgoon LD; Aladjov H; Torres Andón F; Evelo CT; Willighagen EL
Front Genet; 2018; 9():661. PubMed ID: 30622555
[TBL] [Abstract][Full Text] [Related]
6. Semantic characterization of adverse outcome pathways.
Wang RL
Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gaps.
Jaylet T; Coustillet T; Smith NM; Viviani B; Lindeman B; Vergauwen L; Myhre O; Yarar N; Gostner JM; Monfort-Lanzas P; Jornod F; Holbech H; Coumoul X; Sarigiannis DA; Antczak P; Bal-Price A; Fritsche E; Kuchovska E; Stratidakis AK; Barouki R; Kim MJ; Taboureau O; Wojewodzic MW; Knapen D; Audouze K
Front Toxicol; 2024; 6():1285768. PubMed ID: 38523647
[No Abstract] [Full Text] [Related]
8. Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities.
Wiklund L; Caccia S; Pípal M; Nymark P; Beronius A
Front Toxicol; 2023; 5():1183824. PubMed ID: 37229356
[TBL] [Abstract][Full Text] [Related]
9. The potential of AOP networks for reproductive and developmental toxicity assay development.
Knapen D; Vergauwen L; Villeneuve DL; Ankley GT
Reprod Toxicol; 2015 Aug; 56():52-5. PubMed ID: 25889759
[TBL] [Abstract][Full Text] [Related]
10. Adverse outcome pathway (AOP) development I: strategies and principles.
Villeneuve DL; Crump D; Garcia-Reyero N; Hecker M; Hutchinson TH; LaLone CA; Landesmann B; Lettieri T; Munn S; Nepelska M; Ottinger MA; Vergauwen L; Whelan M
Toxicol Sci; 2014 Dec; 142(2):312-20. PubMed ID: 25466378
[TBL] [Abstract][Full Text] [Related]
11. Adverse Outcome Pathway 'Footprinting': A Novel Approach to the Integration of 21st Century Toxicology Information into Chemical Mixtures Risk Assessment.
Lambert JC
Toxics; 2022 Dec; 11(1):. PubMed ID: 36668763
[TBL] [Abstract][Full Text] [Related]
12. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
[TBL] [Abstract][Full Text] [Related]
13. Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429).
Tsamou M; Roggen EL
J Alzheimers Dis Rep; 2022; 6(1):271-296. PubMed ID: 35891639
[TBL] [Abstract][Full Text] [Related]
14. Identification of neurotoxicology (NT)/developmental neurotoxicology (DNT) adverse outcome pathways and key event linkages with in vitro DNT screening assays.
Pitzer EM; Shafer TJ; Herr DW
Neurotoxicology; 2023 Dec; 99():184-194. PubMed ID: 37866692
[TBL] [Abstract][Full Text] [Related]
15. sAOP: linking chemical stressors to adverse outcomes pathway networks.
Aguayo-Orozco A; Audouze K; Siggaard T; Barouki R; Brunak S; Taboureau O
Bioinformatics; 2019 Dec; 35(24):5391-5392. PubMed ID: 31329252
[TBL] [Abstract][Full Text] [Related]
16. A high-level overview of the OECD AOP Development Programme.
Chauhan V; Hamada N; Wilkins R; Garnier-Laplace J; Laurier D; Beaton D; Tollefsen KE
Int J Radiat Biol; 2022; 98(12):1704-1713. PubMed ID: 35938955
[TBL] [Abstract][Full Text] [Related]
17. Adverse outcome pathways and linkages to transcriptomic effects relevant to ionizing radiation injury.
Yu J; Tu W; Payne A; Rudyk C; Cuadros Sanchez S; Khilji S; Kumarathasan P; Subedi S; Haley B; Wong A; Anghel C; Wang Y; Chauhan V
Int J Radiat Biol; 2022; 98(12):1789-1801. PubMed ID: 35939063
[TBL] [Abstract][Full Text] [Related]
18. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
[TBL] [Abstract][Full Text] [Related]
19. From Causal Networks to Adverse Outcome Pathways: A Developmental Neurotoxicity Case Study.
Ramšak Ž; Modic V; Li RA; Vom Berg C; Zupanic A
Front Toxicol; 2022; 4():815754. PubMed ID: 35295214
[TBL] [Abstract][Full Text] [Related]
20. Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations.
Ravichandran J; Karthikeyan BS; Samal A
Sci Total Environ; 2022 Jun; 826():154112. PubMed ID: 35219661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
